Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in the following investor conferences from May 19 to May 21, 2026:
- 2026 RBC Capital Markets Global Healthcare Conference in New York City, presenting on Wednesday, May 20, 2026 at 10:00 AM ET
- 2026 Wells Fargo Virtual Private MedTech Symposium
Andy Doraiswamy (CEO) and Damian Rippole (CFO) will highlight the company’s commercial momentum for its portfolio—including Dayspring® non-pneumatic compression treatment for chronic edema—and share progress on its vascular pipeline and ongoing clinical research.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—highlighting the urgent need for modern, evidence-based, and scalable solutions.
